Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients
Open Access
- 26 August 2008
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 124 (3) , 653-658
Abstract
Little research has been done to test the usefulness of T‐lymphoma invasion and metastasis 1 (Tiam1) as a prognostic marker for hepatocellular carcinoma (HCC). In this study, we investigated Tiam1 expression and its prognostic value for HCC. HCC surgical tissue samples were taken from 152 HCC patients who had been followed up for 5 years. Overexpression of Tiam1 (Tiam1 2+ to 3+) was shown in 63.8% of the cases. The Tiam1 expression level did not correlate with any clinicopathological parameters. However, survival analysis showed that the Tiam1 overexpression group had a significantly shorter overall survival time than the Tiam1 downexpression group (p = 0.008). Multivariate analysis showed that Tiam1 expression was a significant and independent prognostic parameter (p = 0.042) for HCC patients. Tiam1 expression may be a novel and independent predictor for the prognosis of HCC patients.Keywords
This publication has 35 references indexed in Scilit:
- Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinomaHepatology, 2008
- CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinomaCancer Genetics and Cytogenetics, 2008
- Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2007
- Amplification of c‐myc and cyclin D1 genes in primary and metastatic carcinomas of the liverPathology International, 2007
- Lentivirus-Mediated Silencing of Tiam1 Gene Influences Multiple Functions of a Human Colorectal Cancer Cell LineNeoplasia, 2006
- Prognostic relevance of Tiam1 protein expression in prostate carcinomasBritish Journal of Cancer, 2006
- GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factorsNature Reviews Molecular Cell Biology, 2005
- Regulation of p70 S6 Kinase by Complex Formation between the Rac Guanine Nucleotide Exchange Factor (Rac-GEF) Tiam1 and the Scaffold SpinophilinJournal of Biological Chemistry, 2003
- Plexin B Regulates Rho through the Guanine Nucleotide Exchange Factors Leukemia-associated Rho GEF (LARG) and PDZ-RhoGEFJournal of Biological Chemistry, 2002
- Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumoursNature, 2002